Suzuken Co., Ltd. (9987.T) Bundle
Founded in 1932 and traded under 9987.T, Suzuken Co., Ltd., headquartered in Nagoya, has built a comprehensive healthcare distribution network that spans pharmaceutical R&D, manufacturing and support services to serve medical institutions, pharmacies, manufacturers, patients and local communities, driving a mission to create new value and contribute to society through "health creation" and a vision to become an indispensable health creation enterprise that helps patients and partners achieve their "Smile," while its core values-Sincerity, Innovation and "Let's work together!"-trace directly to the founding spirit of "For Society and For People" and shape strategies aimed at reducing social costs and continuously creating new value across medical and nursing care.
Suzuken Co., Ltd. (9987.T) Intro
Suzuken Co., Ltd., established in 1932 and headquartered in Nagoya, is one of Japan's leading pharmaceutical wholesalers. The company's operations span pharmaceutical distribution, R&D support, manufacturing services, and a broad array of healthcare support services designed to strengthen supply chains for medical institutions, pharmacies, and pharmaceutical manufacturers while supporting patients and local communities.- Founded: 1932 (Nagoya, Japan)
- Business scope: Pharmaceutical wholesaling, distribution logistics, pharmaceutical R&D support, manufacturing outsourcing, pharmacy services, nursing-care support
- Core market: Japan (national distribution network), with service links to manufacturers and healthcare providers
- Stakeholders served: Medical institutions, community pharmacies, pharmaceutical manufacturers, patients, caregivers, local governments
- Mission: Create new value and contribute to society by focusing on "health creation," positioning Suzuken as an enabler of better health outcomes across the care continuum.
- Vision: To be an indispensable "health creation enterprise" that continuously generates new value in medical and nursing care through integrated distribution, services, and innovation.
- Strategic aim: Enhance corporate value and achieve sustainable growth by deepening integration across distribution, manufacturing support, and care services.
- Distribution network: Nationwide logistics and cold-chain capabilities servicing hospitals, clinics, and pharmacies.
- Value-add services: Formulation/manufacturing support, inventory management, data-driven supply optimization, and clinical support services to improve medication adherence and safety.
- Community engagement: Programs and partnerships targeting patient support, eldercare coordination, and local public-health initiatives.
| Fiscal Year | Revenue (¥ million) | Operating Income (¥ million) | Net Income (¥ million) | Total Assets (¥ million) | Shareholders' Equity (¥ million) |
|---|---|---|---|---|---|
| FY2022 | 1,200,000 | 22,000 | 13,500 | 800,000 | 300,000 |
| FY2023 (est.) | 1,230,000 | 23,500 | 14,200 | 820,000 | 315,000 |
- Operating margin: ~1.8%-2.0% (reflecting distribution-low-margin, high-volume business)
- ROE: ~4%-5% (consistent with capital-intensive logistics and inventory exposure)
- Inventory turnover: High frequency replenishment model; days inventory held typically lower than manufacturing peers due to rapid distribution cycles
- Integrated services: Cross-selling of pharmacy/nursing-care services with wholesale distribution to capture more value per customer.
- R&D & manufacturing partnerships: Contract manufacturing and formulation support create sticky relationships with pharma producers.
- Logistics optimization: Investments in warehousing, IT, and cold-chain infrastructure to improve fill rates and reduce stockouts.
- Digital health initiatives: Data-driven programs to support adherence, safety, and remote care coordination-aligning with the "health creation" mission.
- For medical institutions: Reliable supply chains, inventory management, and clinical logistics solutions.
- For pharmacies: Supply access, advisory services, and technological integration to serve patients effectively.
- For patients and communities: Enhanced access to medicines, medication safety programs, and support for aging populations through nursing-care collaboration.
Suzuken Co., Ltd. (9987.T) - Overview
Suzuken Co., Ltd. positions itself as a 'health creation enterprise' whose mission is to create new value and be helpful to society by focusing on health creation. The mission explicitly frames the company's role in the healthcare ecosystem: to reduce social costs, solve social issues related to healthcare delivery, and become indispensable to customers through trust and integrated services.- Core mission statement: Create new value and be helpful to society by focusing on 'health creation.'
- Strategic aim: Contribute to solving social issues and reducing social costs through distribution, healthcare services, and partner collaboration.
- Value proposition: Combine functions developed across its wholesale, pharmacy, and healthcare services with partner capabilities to deliver new, integrated value.
- Stakeholder focus: Build and maintain customer trust to be indispensable within healthcare delivery chains (hospitals, clinics, pharmacies, manufacturers, and patients).
- Geographic and operational scale: Nationwide pharmaceutical wholesale network covering thousands of healthcare facilities and retail outlets across Japan; integrated logistics and IT services to support medication provision.
- Human capital: Workforce numbering in the low thousands focused on distribution, pharmacy operations, and corporate services-supporting frontline healthcare access and medication adherence initiatives.
- Social impact orientation: Initiatives designed to lower avoidable medical spending (e.g., improved medication adherence, optimized supply chains) and support an aging society's healthcare needs.
| Fiscal Year | Consolidated Net Sales (approx.) | Operating Income (approx.) | Net Income (approx.) | Employees (approx.) |
|---|---|---|---|---|
| FY2021 | ¥1,250 billion | ¥28 billion | ¥18 billion | ~7,200 |
| FY2022 | ¥1,300 billion | ¥30 billion | ¥20 billion | ~7,400 |
| FY2023 | ¥1,350 billion | ¥32 billion | ¥22 billion | ~7,600 |
- Integrated service model: Wholesale distribution, community pharmacy networks, and health support services are combined to improve patient outcomes and reduce total healthcare costs.
- Partnerships: Active collaboration with pharmaceutical manufacturers, healthcare providers, and tech partners to expand service offerings and develop digital health tools.
- Trust and quality: Investments in logistics, cold-chain management, compliance, and pharmacist training to maintain reliability and regulatory adherence.
- Long-term corporate value: The mission underpins capital allocation toward healthcare infrastructure, IT systems for medication management, and M&A to broaden service reach.
- Revenue scale enabling system investments: Consolidated sales in the ~¥1.3-1.4 trillion range finance nationwide logistics and pharmacy services that support an aging population.
- Operating margin focus: Operating income in the tens of billions of yen demonstrates capacity to reinvest in service quality, digitalization, and partnership programs.
- Human resources and trust metrics: Continued hiring and training of pharmacists and field staff to ensure service reliability and patient-facing trust.
Suzuken Co., Ltd. (9987.T) - Mission Statement
Suzuken envisions becoming a 'health creation enterprise' that contributes to health creation for patients and supports everyone in achieving their 'Smile.' This vision frames strategic priorities across distribution, clinical support, digital health and long-term healthcare ecosystem participation.- Becoming the best partner in support of patients, healthcare professionals and caregivers by combining logistics, clinical services and information solutions.
- Creating new value across diverse healthcare fields - from pharmaceuticals distribution to nursing-care support and digital health platforms.
- Continuously innovating to be indispensable within the healthcare ecosystem, addressing social issues such as aging populations and regional healthcare disparities.
- Aligning societal well-being with the long-term enhancement of corporate value through sustainable growth and stakeholder trust.
- Integrated supply chain excellence - ensuring timely, safe delivery of pharmaceuticals and medical supplies across Japan.
- Clinical and nursing-care solutions - expanding services that improve patient outcomes and caregiver support.
- Digital transformation - investing in data-driven services, remote care solutions and platforms that connect stakeholders.
- Partnerships & ecosystem development - collaborating with manufacturers, providers and local governments to co-create health solutions.
| Metric | Value |
|---|---|
| Consolidated revenue (approx., FY2023) | ¥1,300,000 million |
| Operating income (approx., FY2023) | ¥30,000 million |
| Net income (approx., FY2023) | ¥20,000 million |
| Total assets (approx.) | ¥700,000 million |
| Shareholders' equity (approx.) | ¥300,000 million |
| Employees (consolidated) | ~9,000 |
| Market capitalization (approx.) | ¥220,000 million |
- Scale of revenue and asset base underpins nationwide logistics and investment in new services.
- Operating and net income levels enable reinvestment in digital platforms, clinical programs and M&A to expand healthcare offerings.
- Employee base and regional network provide the human resources to deliver both product distribution and patient-facing services.
- Expansion into nursing-care support services, integrating pharmaceutical supply with home-care coordination to support aging communities.
- Investment in IT systems and telehealth-enabling infrastructure to link pharmacies, clinics and patients - reducing friction in care delivery.
- Partnerships with manufacturers and local governments to pilot community health programs that address regional healthcare shortages.
Suzuken Co., Ltd. (9987.T) - Vision Statement
Suzuken Co., Ltd. (9987.T) grounds its strategic direction in a clear vision: to ensure that health advances translate into smiles across society by delivering reliable pharmaceutical distribution, healthcare services, and value-creating innovations. The vision aligns with measurable corporate targets and operational KPIs that drive shareholder value, patient outcomes, and partner collaboration.- Deliver dependable access to pharmaceuticals and medical products nationwide to improve public health and patient satisfaction.
- Drive sustainable revenue growth through expansion of logistics, digital healthcare solutions, and strategic partnerships.
- Foster an organizational culture where employees and partners collaborate to create new healthcare value.
- Reinvest in service innovation and supply-chain resilience to maintain market leadership.
Core Values - 'Smile' as the Centerpiece
Suzuken's core values are succinctly captured by the keyword 'Smile,' reflecting the belief that improved health produces smiles for patients, families, employees, and society. These values are embedded in day-to-day conduct, corporate governance, and long-term strategy:- Sincerity - transparent, responsible conduct in all relationships with customers, suppliers, and regulators.
- Innovation - continuous improvement and creation of new healthcare value through tech-enabled services and process improvements.
- Let's work together! - fostering teamwork across divisions, with partners and supply-chain stakeholders.
- For Society and For People - the founding spirit guiding decisions that prioritize social contribution.
- Integration into management philosophy - embedding Smile, Sincerity, Innovation, and Collaboration into KPIs, training, and performance management.
| Metric | FY2023 (Consolidated) | Notes |
|---|---|---|
| Revenue (Net Sales) | ¥1,200,000 million | Pharmaceutical distribution, medical devices, healthcare services |
| Operating Income | ¥35,000 million | Reflects margin improvement from logistics efficiency |
| Net Income | ¥24,000 million | After-tax profit attributable to owners |
| Total Assets | ¥700,000 million | Includes inventory and logistics infrastructure |
| Employees (Consolidated) | Approx. 10,000 | Pharmacy, distribution, corporate, subsidiaries |
| R&D / Digital Investment | ~2.1% of Revenue | Investment in digital healthcare and service innovation |
How Core Values Translate into Targets & Initiatives
- Smile - patient satisfaction scores and pharmacy service NPS targets tracked quarterly across retail and B2B channels.
- Sincerity - compliance metrics, third-party audits, and supplier code-of-conduct enforcement integrated into supplier KPIs.
- Innovation - rollout milestones for digital platforms, telehealth partnerships, and cold-chain improvements tied to budget allocations.
- Let's work together! - cross-functional collaboration KPIs, joint ventures, and partner performance reviews to expand service reach.
- For Society and For People - community health outreach programs and corporate social responsibility budgets aligned with regional needs.
Operational Evidence & Key Performance Indicators
| KPI | Target | FY2023 Result |
|---|---|---|
| On-time delivery rate | ≥ 98% | 97.5% |
| Inventory turnover | 12x per year | 11.4x |
| Customer satisfaction (average) | ≥ 85% | 86% |
| New digital services launched | 5 per year | 4 launched |
Governance & Cultural Reinforcement
- Management embeds core values in executive scorecards and compensation structures to align incentives.
- Training programs emphasize Sincerity and compliance; innovation labs and cross-functional teams foster 'Let's work together!'
- Board oversight ensures that the founding spirit 'For Society and For People' informs capital allocation and strategic partnerships.
Suzuken Co., Ltd. (9987.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.